Ophthalmoplegia Market Report and Forecast 2024-2032

Ophthalmoplegia Market Outlook

The ophthalmoplegia market size was valued at USD 1032.7 million in 2023, driven by the increasing advancements in healthcare and pharmaceutical industry across the 7 major markets. The market is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032, with the value likely to reach USD 2130.2 million by 2032.

Ophthalmoplegia: Introduction

Ophthalmoplegia is the weakness of the eye muscles, affecting one or more than one of the six muscles holding the eye in place and controlling its movement. It can be further segmented into chronic progressive external ophthalmoplegia and internal ophthalmoplegia. People suffering from ophthalmoplegia may have blurred or double vision, and even misaligned eyes in some cases. It is mostly diagnosed through MRI or CT scans.

Ophthalmoplegia Market Analysis

The incidence of ophthalmoplegia is slightly higher in people affected with diabetes. Since the prevalence of diabetes is growing due to the changes in modern lifestyles and unhealthy dietary practices, the ophthalmoplegia market demand has also observed an upswing. Along with diabetes, patients affected by multiple sclerosis or Graves’ disease are also at a risk of developing the condition.

With the rising preference for minimally invasive surgical interventions, silicone sling procedure is commonly performed as an ophthalmoplegia treatment. This procedure is used to treat drooping eyelids, a critical symptom of the disease. It is performed with the help of a Seiff silicone suspension and the silicone is guided in the muscle through a stab incision. This procedure offers multiple advantages like early recovery, less surgical time, and no multiple incisions when compared to other methods.

Apart from surgical interventions and drugs like tetracycline, corticosteroid treatment, and botulinum toxin, vitamins are also used quite frequently. However, adopting traditional Chinese medicine as a complementary and alternative method, acupuncture is also being investigated as a potential therapeutic method. With a vision to cater to a diverse set of patients, scientists are looking into various approaches, which are poised to boost the ophthalmoplegia market value in the forecast period.

 
Ophthalmoplegia Market Segmentation

Market Breakup by Type

• External Ophthalmoplegia

• Internuclear Opthalmoplegia

Market Breakup by Treatment Type

• Surgery

• Drug Treatment

• Others

Market Breakup by End User

• Hospital and Clinics

• Ambulatory Clinics

• Others

Market Breakup by Region

• United States

• EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom

• Japan

Ophthalmoplegia Market Overview

North America has been dominating the ophthalmoplegia market share owing to factors like a well-developed healthcare infrastructure and the increased presence of prominent pharmaceutical companies. In addition, companies have been expanding their product portfolios for better patient outcomes.

Europe is another major market with a high emphasis on offering better healthcare solutions to patients. With substantial geriatric population, the region may experience more ophthalmoplegia cases in upcoming years. Therefore, there has been significant focus on developing innovative and highly effective treatment alternatives. The rising technical advancements that incorporate artificial intelligence and machine learning into drug development are some of the critical trends shaping the market value in the region.

The Asia Pacific is projected to witness significant ophthalmoplegia market growth which can be attributed to rising healthcare investments from the native governments as well as foreign companies. Along with improving the healthcare infrastructure, several influential pharmaceutical companies are setting up new research labs and clinics to put the easily available resources in the area to use.

Ophthalmoplegia Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• F. Hoffmann-La Roche Ltd

• Bausch Health

• Johnson & Johnson Services, Inc.

• Medline Industries

• Santen Pharmaceutical Co.

• Novartis AG

• Abbott

• Essilor

• Astellas Pharma Inc.

• Enzon Pharmaceuticals

• Amritt, Inc.

• NIDEK CO.

• Carl Zeiss AG

• Santen Pharmaceutical Co.

• Medline Industries

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report